My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 252

    1.

    Novel therapeutic strategies for leiomyomas: targeting growth factors and their receptors.

    Nowak RA.

    Environ Health Perspect. 2000 Oct;108 Suppl 5:849-53.PMID: 11035994 [PubMed - indexed for MEDLINE]Related articles

    2.

    Isolation and characterization of heparin-binding growth factors in human leiomyomas and normal myometrium.

    Mangrulkar RS, Ono M, Ishikawa M, Takashima S, Klagsbrun M, Nowak RA.

    Biol Reprod. 1995 Sep;53(3):636-46.PMID: 7578688 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Immunohistochemical localization of growth factors and their receptors in uterine leiomyomas and matched myometrium.

    Dixon D, He H, Haseman JK.

    Environ Health Perspect. 2000 Oct;108 Suppl 5:795-802.PMID: 11035985 [PubMed - indexed for MEDLINE]Related articles

    4.

    The management of uterine leiomyomas.

    Lefebvre G, Vilos G, Allaire C, Jeffrey J, Arneja J, Birch C, Fortier M, Wagner MS; Clinical Practice Gynaecology Committee, Society for Obstetricians and Gynaecologists of Canada.

    J Obstet Gynaecol Can. 2003 May;25(5):396-418; quiz 419-22.PMID: 12738981 [PubMed - indexed for MEDLINE]Related articles

    5.

    Pirfenidone: a novel pharmacological agent that inhibits leiomyoma cell proliferation and collagen production.

    Lee BS, Margolin SB, Nowak RA.

    J Clin Endocrinol Metab. 1998 Jan;83(1):219-23.PMID: 9435445 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Interferon-alpha is a potent inhibitor of basic fibroblast growth factor-stimulated cell proliferation in human uterine cells.

    Lee BS, Stewart EA, Sahakian M, Nowak RA.

    Am J Reprod Immunol. 1998 Jul;40(1):19-25.PMID: 9689356 [PubMed - indexed for MEDLINE]Related articles

    7.

    Expression of the hypoxically regulated angiogenic factor adrenomedullin correlates with uterine leiomyoma vascular density.

    Hague S, Zhang L, Oehler MK, Manek S, MacKenzie IZ, Bicknell R, Rees MC.

    Clin Cancer Res. 2000 Jul;6(7):2808-14.PMID: 10914728 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Human leiomyoma smooth muscle cells show increased expression of transforming growth factor-beta 3 (TGF beta 3) and altered responses to the antiproliferative effects of TGF beta.

    Lee BS, Nowak RA.

    J Clin Endocrinol Metab. 2001 Feb;86(2):913-20.PMID: 11158066 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Aberrant expression of Cyr61, a member of the CCN (CTGF/Cyr61/Cef10/NOVH) family, and dysregulation by 17 beta-estradiol and basic fibroblast growth factor in human uterine leiomyomas.

    Sampath D, Zhu Y, Winneker RC, Zhang Z.

    J Clin Endocrinol Metab. 2001 Apr;86(4):1707-15.PMID: 11297607 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Fibroids: pathophysiology and current medical treatment.

    Nowak RA.

    Baillieres Best Pract Res Clin Obstet Gynaecol. 1999 Jun;13(2):223-38. Review.PMID: 10755039 [PubMed - indexed for MEDLINE]Related articles

    11.

    Differential expression of receptor tyrosine kinases (RTKs) and IGF-I pathway activation in human uterine leiomyomas.

    Yu L, Saile K, Swartz CD, He H, Zheng X, Kissling GE, Di X, Lucas S, Robboy SJ, Dixon D.

    Mol Med. 2008 May-Jun;14(5-6):264-75. Erratum in: Mol Med. 2008 Jul-Aug;14(7-8):538. PMID: 18231572 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Human uterine leiomyoma cells: binding and growth responses to epidermal growth factor, platelet-derived growth factor, and insulin.

    Fayed YM, Tsibris JC, Langenberg PW, Robertson AL Jr.

    Lab Invest. 1989 Jan;60(1):30-7.PMID: 2536127 [PubMed - indexed for MEDLINE]Related articles

    13.

    Expression, menstrual cycle-dependent activation, and bimodal mitogenic effect of transforming growth factor-beta1 in human myometrium and leiomyoma.

    Arici A, Sozen I.

    Am J Obstet Gynecol. 2003 Jan;188(1):76-83.PMID: 12548199 [PubMed - indexed for MEDLINE]Related articles

    14.

    Potentiation response of cultured human uterine leiomyoma cells to various growth factors by endothelin-1: role of protein kinase C.

    Eude I, Dallot E, Vacher-Lavenu MC, Chapron C, Ferre F, Breuiller-Fouche M.

    Eur J Endocrinol. 2001 May;144(5):543-8.PMID: 11331222 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    The growth arrest-specific gene CCN5 is deficient in human leiomyomas and inhibits the proliferation and motility of cultured human uterine smooth muscle cells.

    Mason HR, Lake AC, Wubben JE, Nowak RA, Castellot JJ Jr.

    Mol Hum Reprod. 2004 Mar;10(3):181-7. Epub 2004 Jan 29.PMID: 14981145 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Comparative effects of SPRM asoprisnil (J867) on proliferation, apoptosis, and the expression of growth factors in cultured uterine leiomyoma cells and normal myometrial cells.

    Ohara N, Morikawa A, Chen W, Wang J, DeManno DA, Chwalisz K, Maruo T.

    Reprod Sci. 2007 Dec;14(8 Suppl):20-7.PMID: 18089606 [PubMed - indexed for MEDLINE]Related articles

    17.

    Growth advantage of human leiomyoma cells compared to normal smooth-muscle cells due to enhanced sensitivity toward insulin-like growth factor I.

    van der Ven LT, Gloudemans T, Roholl PJ, van Buul-Offers SC, Bladergroen BA, Welters MJ, Sussenbach JS, den Otter W.

    Int J Cancer. 1994 Nov 1;59(3):427-34.PMID: 7927953 [PubMed - indexed for MEDLINE]Related articles

    18.

    The antifibrotic drug halofuginone inhibits proliferation and collagen production by human leiomyoma and myometrial smooth muscle cells.

    Grudzien MM, Low PS, Manning PC, Arredondo M, Belton RJ Jr, Nowak RA.

    Fertil Steril. 2009 Jan 8. [Epub ahead of print]PMID: 19135664 [PubMed - as supplied by publisher]Related articles

    19.

    New concepts in the treatment of uterine leiomyomas.

    Stewart EA, Nowak RA.

    Obstet Gynecol. 1998 Oct;92(4 Pt 1):624-7.PMID: 9764641 [PubMed - indexed for MEDLINE]Related articles

    20.

    Potential nonhormonal therapeutics for medical treatment of leiomyomas.

    Young SL, Al-Hendy A, Copland JA.

    Semin Reprod Med. 2004 May;22(2):121-30. Review.PMID: 15164307 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity